Navigation Links
UCF researchers discover a new protein family implicated in inflammatory diseases
Date:3/10/2008

A University of Central Florida research team has discovered a new protein family that may play an important role in preventing inflammatory diseases such as arthritis, some forms of cancer and even heart disease.

The findings that in the future may aid the bodys defense system are published in the March 7 edition of the Journal of Biological Chemistry. The research is partially funded by the National Institutes of Health.

What we found is a family of proteins that control macrophage activation, researcher Mingui Fu said from a laboratory in the Burnett School of Biomedical Sciences at UCF.

Macrophages are the bodys self-cleaners. They live in the bloodstream and are called to action when bacteria or other foreign objects attack. Scientists have been studying what triggers them, but no one has come up with a step-by-step process yet. Once triggered, macrophages travel to the infection site and gobble up the invader, helping the body heal. The attack is manifested by inflammation at the infection site.

When everything works right, the inflammation goes away and the persons health improves. But when macrophages go awry, they can cause more harm than good. Sometimes the macrophages mistake the bodys own organs for invaders and attack, and that can cause arthritis or some forms of cancer. Sometimes the cleaners fail to detect threats, such as malignant cancer cells, which then go unregulated and can turn into fatal tumors.

When Fu arrived at UCF in 2007, he teamed up with Pappachan Kolattukudy, the director of the Burnett School of Biomedical Sciences. Kolattukudys laboratory has been studying for two decades how a small protein called MCP, produced at the site of injury, infection or inflammation, attracts macrophages to the site to clean up. Last year his team published the discovery of a novel gene called MCPIP that is turned on by MCP. They showed that MCPIP is involved in the development of ischemic heart failure, the leading cause of death. This team has been exploring how this new gene works.

MCPIP turns out to be the first member of a small, newly discovered gene family called CCCH-Zinc fingure proteins. This family appears to switch the macrophages on and off. The researchers continue to study different aspects of the proteins because of the possibility that they will be critical in treating and curing inflammatory diseases.

Kolattukudy said the new protein holds a lot of promise, but more studies are needed.

Because this novel protein has key roles to play in the major inflammatory diseases such as cardiovascular disease, cancer and obesity-induced type2 diabetes, it is a promising drug target, Kolattukudy said. We have a patent application filed on this protein for that purpose.


'/>"/>

Contact: Zenaida Gonzalez Kotala
zkotala@mail.ucf.edu
407-823-6120
University of Central Florida
Source:Eurekalert

Related medicine news :

1. Size does matter: Researchers adapt drug dosing to body size
2. Burroughs Wellcome Fund grants $9.75 million towards translational researchers
3. Researchers Design Promising Cancer Drug
4. Case Western Reserve University researchers identify colorectal cancer gene
5. On a roll: MIT researchers devise new cell-sorting system
6. Einstein researchers genetically engineer immune cells into potent weapons for battling HIV
7. Researchers control growth rate of replacement blood vessels, tissues
8. New protein discovery helps researchers understand autoimmune diseases
9. UF researchers warn parents about dangers of childhood foot burns
10. UCLA researchers find blood stem cells originate and are nurtured in the placenta
11. UCSF researchers validate new model for breast cancer risk assessment in multiple ethnic groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
(Date:8/18/2017)... Woodlands, TX (PRWEB) , ... August 18, 2017 ... ... protection assistance and financial planning services to communities in east Texas, is launching ... Pediatric Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... The Golseth ... in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to provide ... , In early June of this year, Christina and her children returned from out ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the body ... with its product now available through Jet.com. , After 25 years of development, ... drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)...  Endo International plc (NASDAQ: ENDP ) ... all known U.S. mesh product liability claims and that ... remaining U.S. claims at reasonable values. Under the agreements, ... quarter of 2017 and continuing through the fourth quarter ... results, the Company intends to increase its mesh product ...
(Date:8/2/2017)... AROMAS, Calif. , Aug. 2, 2017 /PRNewswire/ ... by Continental Who,s Who as a Pinnacle Lifetime ... currently the Key Account Manager at Turing Pharmaceuticals, ... communications, negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience ...
(Date:8/1/2017)... Aug. 1, 2017   CerSci Therapeutics , a ... Texas , has received notice from the National ... of Health (NIH) that it has been awarded a ... over $650,000 in 2017 with an additional $1,000,000 to ... New Drug application of their lead non-opioid drug candidate ...
Breaking Medicine Technology: